CIBC Private Wealth Group
AEON icon

CIBC Private Wealth Group’s AEON Biopharma AEON Stock Holding History

CIBC Private Wealth Group’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$36 Hold
33
– – ﹤0.01% 3338
2025
Q3 		$27 Hold
33
– – ﹤0.01% 3033
2025
Q2 		$25 Hold
33
– – ﹤0.01% 3025
2025
Q1 		$14 Sell
33
-1
-3% -$7 ﹤0.01% 3042
2024
Q4 		$459 Hold
34
– – ﹤0.01% 2853
2024
Q3 		$2.54K Buy
+34
New +$2.99K ﹤0.01% 2759

Other funds holding AEON

DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIBC Private Wealth Group's AEON Position: Q4 2025 in Review

CIBC Private Wealth Group held its AEON Biopharma (AEON) position steady in Q4 2025 at 33 shares worth $36. The position accounts for ﹤0.01% of the portfolio, ranked #3338.

CIBC Private Wealth Group first reported a position in AEON in Q3 2024 and has held it in 6 quarters since. The position peaked at $2.54K in Q3 2024. 22 funds tracked by Wall St. Rank hold AEON as of Q4 2025.

  • CIBC Private Wealth Group held 33 shares of AEON Biopharma worth $36 as of Q4 2025.
  • CIBC Private Wealth Group left its AEON Biopharma share count unchanged in Q4 2025.
  • AEON Biopharma made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #3338 holding.
  • CIBC Private Wealth Group first reported a position in AEON Biopharma in Q3 2024 and has held it in 6 quarters since.
  • CIBC Private Wealth Group's AEON Biopharma position peaked at $2.54K in Q3 2024.
  • 22 funds tracked by Wall St. Rank held AEON Biopharma as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.